A new class of drugs could prevent resistant COVID-19 variants, study finds
The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their arsenal for treating drug-resistant infections. Researchers have now discovered that a new class of oral drugs that acts directly on human cells can inhibit a diverse range of pathogenic SARS-CoV-2 strains.
Materials provided by Yale University. Original written by Isabella Backman. Note: Content may be edited for style and length.
Source link aaaaa